CDTX logo

CDTX
Cidara Therapeutics Inc

9,085
Mkt Cap
$6.84B
Volume
17.29M
52W High
$218.85
52W Low
$14.33
PE Ratio
-18.48
CDTX Fundamentals
Price
$217.71
Prev Close
$105.99
Open
$217.20
50D MA
$95.60
Beta
0.63
Avg. Volume
973,658.52
EPS (Annual)
-$26.46
P/B
15.12
Rev/Employee
$33,552.63
Loading...
Loading...
News
all
press releases
Value Stocks To Watch Now - November 15th
Invesco QQQ, CoreWeave, Cidara Therapeutics, ProShares UltraPro Short QQQ, and Circle Internet Group are the five Value stocks to watch today, according to MarketBeat's stock screener tool. Value...
MarketBeat·17h ago
News Placeholder
More News
News Placeholder
Medical Stocks To Watch Today - November 15th
Eli Lilly and Company, Cidara Therapeutics, UnitedHealth Group, Pfizer, and Metsera are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are...
MarketBeat·18h ago
News Placeholder
Cidara Therapeutics (NASDAQ:CDTX) Sets New 12-Month High - Here's Why
Cidara Therapeutics (NASDAQ:CDTX) Sets New 52-Week High - Still a Buy...
MarketBeat·21h ago
News Placeholder
Cidara Therapeutics Sees Unusually Large Options Volume (NASDAQ:CDTX)
Cidara Therapeutics, Inc. (NASDAQ:CDTX - Get Free Report) was the recipient of unusually large options trading activity on Friday. Investors bought 15,470 call options on the stock. This represents...
MarketBeat·22h ago
News Placeholder
Top Value Stocks To Watch Now - November 14th
Invesco QQQ, CoreWeave, Cidara Therapeutics, ProShares UltraPro Short QQQ, Circle Internet Group, Nebius Group, and Metsera are the seven Value stocks to watch today, according to MarketBeat's stock...
MarketBeat·2d ago
News Placeholder
Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their...
PR Newswire·2d ago
News Placeholder
Cidara Therapeutics Shares Soar 105% After Merck Agrees To $9.2B Takeover Deal
(RTTNews) - Cidara Therapeutics, Inc. (CDTX) climbed 105.68% to $217.99, up $112.00, after it announced that Merck & Co. will acquire all outstanding shares for $221.50 per share in cash, valuing the...
Nasdaq News: Markets·2d ago
News Placeholder
Gold Tumbles Over 2%; Cidara Therapeutics Shares Spike Higher
read more...
Benzinga·2d ago
News Placeholder
Shareholder Alert: The Ademi Firm investigates whether Cidara Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Cidara Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders Shareholder Alert: The Ademi Firm investigates whether Cidara...
PR Newswire·2d ago
News Placeholder
Merck Makes Big Bet On Flu Protection With Cidara Buyout
Merck (NYSE: MRK) to acquire Cidara (NASDAQ: CDTX) for $9.2 billion, diversifying its portfolio with CD388.read more...
Benzinga·2d ago

Latest CDTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.